These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 24715690)
1. Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Fujiwara T; Katsuda T; Hagiwara K; Kosaka N; Yoshioka Y; Takahashi RU; Takeshita F; Kubota D; Kondo T; Ichikawa H; Yoshida A; Kobayashi E; Kawai A; Ozaki T; Ochiya T Stem Cells; 2014 Apr; 32(4):959-73. PubMed ID: 24715690 [TBL] [Abstract][Full Text] [Related]
2. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma. Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1. Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921 [TBL] [Abstract][Full Text] [Related]
6. CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma. He A; Yang X; Huang Y; Feng T; Wang Y; Sun Y; Shen Z; Yao Y J Cell Biochem; 2015 Aug; 116(8):1719-29. PubMed ID: 25736420 [TBL] [Abstract][Full Text] [Related]
7. miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo. Duan Z; Gao Y; Shen J; Choy E; Cote G; Harmon D; Bernstein K; Lozano-Calderon S; Mankin H; Hornicek FJ Mol Oncol; 2017 Feb; 11(2):151-166. PubMed ID: 28145098 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Ji F; Zhang H; Wang Y; Li M; Xu W; Kang Y; Wang Z; Wang Z; Cheng P; Tong D; Li C; Tang H Bone; 2013 Sep; 56(1):220-6. PubMed ID: 23756231 [TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Wang Z; Cai H; Lin L; Tang M; Cai H Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients. Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643 [TBL] [Abstract][Full Text] [Related]
12. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival. Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692 [TBL] [Abstract][Full Text] [Related]
13. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells. Du JY; Wang LF; Wang Q; Yu LD Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572 [TBL] [Abstract][Full Text] [Related]
14. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025 [TBL] [Abstract][Full Text] [Related]
15. THE INFLUENCE AND REGULATORY MECHANISM OF Y-BOX BINDING PROTEIN 1 IN OSTEOSARCOMA AND ITS SIGNIFICANCE. Zhou WP; Liu X; Yang Y; Liu YF J Biol Regul Homeost Agents; 2015; 29(2):485-91. PubMed ID: 26122241 [TBL] [Abstract][Full Text] [Related]
16. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625 [TBL] [Abstract][Full Text] [Related]
17. Regulatory effects of microRNA‑184 on osteosarcoma via the Wnt/β‑catenin signaling pathway. Du Z; Li F; Wang L; Huang H; Xu S Mol Med Rep; 2018 Aug; 18(2):1917-1924. PubMed ID: 29916553 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma. Zou P; Ding J; Fu S Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202 [TBL] [Abstract][Full Text] [Related]
19. GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma. Dong J; Bi B; Zhang L; Gao K Oncol Rep; 2016 Sep; 36(3):1585-91. PubMed ID: 27460987 [TBL] [Abstract][Full Text] [Related]
20. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]